Related Experiment Video

Updated: Jan 7, 2026

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
08:22

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy

Published on: March 12, 2018

15.5K

Invivo gene editing for lipid management: An early perspective from ANGPTL3-targeted CRISPR-Cas9 therapy

Luke J Laffin1, Steven E Nissen1

  • 1Section of Preventive Cardiology and Rehabilitation, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA; Cleveland Clinic Coordinating Center for Clinical Research, Cleveland Clinic Foundation, Cleveland, OH, USA.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|January 4, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.6K
CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation
08:31

CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation

Published on: June 20, 2019

14.6K

Related Experiment Videos

Last Updated: Jan 7, 2026

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
08:22

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy

Published on: March 12, 2018

15.5K
Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.6K
CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation
08:31

CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation

Published on: June 20, 2019

14.6K

Related Concept Videos

CRISPR01:59

CRISPR

57.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.4K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

1.6K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.6K

Articles linked to this work by shared authors, journal, and citation graph.

Safety and lipoprotein(a)-lowering effects of Kylo-11, a non-canonical, long-duration small interfering RNA targeting lipoprotein(a): a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial.

Lancet (London, England)·2026

Bempedoic Acid and Venous Thromboembolism Risk Among Statin-Intolerant Patients: A Post Hoc Analysis of the CLEAR Outcomes Randomized Clinical Trial.

JAMA cardiology·2026

Clonal hematopoiesis of indeterminate potential and heart disease: What every internist needs to know.

Cleveland Clinic journal of medicine·2026

Efficacy of Tonlamarsen in Patients With Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial.

Journal of the American College of Cardiology·2026

Aldosterone synthase inhibition in hypertension: an evolving therapeutic strategy.

Current opinion in cardiology·2026

Endothelial triple-pathway vasorelaxation as an adjunctive strategy in resistant hypertension.

Journal of hypertension·2026

Cryo-thermal therapy reprograms myeloid cells into CCL5+ mature phenotype to increase T-cell infiltration and potentiates anti-PD-1 therapy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Targeting the miR-3156-3p/K+ channel axis suppresses viral release and paralysis in enterovirus D68 infection.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Receptor-Ligand Matching for Precision Allogeneic NK Cell Cancer Therapies.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Decoupling reactogenicity from efficacy enables safer mRNA vaccines, AAV gene delivery, and in vivo base editing.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Planning advanced therapy trials for Huntington's Disease: ethical considerations.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Clinical and biochemical correction of a patient with neurodegenerative Mucopolysaccharidosis IIIA using hematopoietic stem cell gene therapy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

An additive-enhanced membrane chromatography approach for improved plasmid DNA recovery.

Preparative biochemistry & biotechnology·2026

Separation of 90Y Microspheres and Imaging with PET/CT: Phantom Study.

Molecular imaging and radionuclide therapy·2026

Pulmonary delivery of ivacaftor via proliposomal dry powder inhalers for cystic fibrosis therapy.

Journal of liposome research·2026

Boosting oral bioavailability of taraxasterol via a nanocrystal-mucoadhesive micropatch platform for potent multi-mechanistic protection against drug-induced liver injury.

Materials today. Bio·2026

Additive-free pectin-rich macromolecular films from citrus peel: Process-controlled composition, colloidal structure, and functional properties.

Bioresource technology·2026

Activation by statins unveils two putative agonist binding sites in the pore domain of TRPA1.

Biochimica et biophysica acta. Molecular cell research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us